• #policyethx
  • Aduhelm
  • PanFab
  • c
  • NEJM
  • .
  • #COVIDLawBriefing
  • Outspoken Oncology Podcast
  • Generic But Expensive
  • Antitrust and Pharmaceuticals
  • The U.S. Opioid Epidemic: Where Do We Go From Here?
  • Tax Cuts and Jobs act
  • The Ethics of Health Care Reform

Michael S. Sinha, MD, JD, MPH is Assistant Professor of Law in the Center for Health Law Studies at Saint Louis University School of Law. Prior teaching roles include Adjunct Faculty in the Beazley Institute for Health Law and Policy at Loyola University Chicago School of Law, Visiting Scholar in the Center for Health Policy and Law at Northeastern University School of Law, and Lecturer in Public Health at California State University, East Bay. He has continuing research relationships with the Harvard-MIT Center for Regulatory Science at Harvard Medical School, the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women’s Hospital, and the Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen.

Medical publications have appeared in NEJM, JAMAJAMA Internal Medicine, JAMA Network OpenMayo Clinic Proceedings, Anesthesiology, CHESTPLOS MedicineHealth Affairs, the American Journal of Public Health, and the American Journal of Bioethics. His legal scholarship includes articles in the Journal of Legal Medicine, the American Journal of Law & Medicine, the Journal of Law, Medicine & Ethics, the Harvard Law & Policy Review, the Food and Drug Law Journal, the Stanford Law & Policy Review, the Journal of Law and the Biosciences, the Hastings Law Journal, and the Minnesota Journal of Law, Science & Technology.